机译:基于药代动力学参数的替考拉宁最佳剂量的治疗,用于治疗耐甲氧西林金黄色葡萄球菌感染的重症监护病房
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan;
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan;
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan;
Laboratory of Pathophysiology II, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku-ku, Nagoya, Aichi, 468-8503, Japan;
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan;
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan;
Teicoplanin (TEC); Pharmacokinetics (PK); Intensive care units (ICU); Methicillin-resistant Staphylococcus aureus (MRSA);
机译:基于药代动力学参数的替考拉宁最佳剂量探讨重症监护病房耐甲氧西林金黄色葡萄球菌感染的治疗
机译:Vancomycin在通风密集护理单位患者中消除呼吸道分泌物的致病性分泌物的致病症是无效的:临床和药代动力学的观点
机译:重症监护病房耐甲氧西林金黄色葡萄球菌细菌血症的经验性体重为基础的万古霉素
机译:以用户为中心的有效基于网络的患者教育发展:耐甲氧西林金黄色葡萄球菌的案例研究
机译:德克萨斯州休斯敦三级护理中心危重住院患者中耐甲氧西林金黄色葡萄球菌的患病率和危险因素:一项积极的监测试点项目。
机译:重症监护病房耐甲氧西林金黄色葡萄球菌细菌血症的经验性体重为基础的万古霉素
机译:耐甲氧西林金黄色葡萄球菌的鼻咽定植和重症监护病房患者的死亡率耐甲氧西林金黄色葡萄球菌的鼻腔定植和重症监护病房患者的死亡率耐甲氧西林金黄色葡萄球菌的鼻腔定植和死亡率重症监护病房